SM

Starfish Medicines at ObesityWeek 2026

Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website

Starfish Medicines brings 2 presentations to ObesityWeek 2026 in National Harbor. Its sessions present preclinical work on antibody peptide conjugates for obesity. One shows the anti-myostatin-incretin conjugate STAR-306 improving lean mass retention in a DIO model, and another characterizes an anti-GIPR-GLP1/amylin antibody peptide conjugate.

OrganizationObesityWeek 2026 Attendance
SM
Starfish Medicines
Biotech
Developer of antibody-peptide conjugates, working on anti-myostatin and anti-GIPR candidates for obesity.
Poster
Sat Nov 14
7:30pm–8:30pm
Poster
Sat Nov 14
7:30pm–8:30pm

Explore the full ObesityWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in National Harbor. Leave your work email and we’ll be in touch.

Privacy

Download the full ObesityWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Starfish Medicines

Tell us what you sell and we’ll find the people at Starfish Medicines most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction